In der nachfolgenden Tabelle sind das bisherige Erfahrungswissen und wissenschaftliche Wissen alphabetisch nach Beschwerden aufgelistet. Bei den einzelnen Beschwerden werden die Geräteentstellungen exemplarisch für das Tiny Scan W angegeben, können aber auch bei jedem anderen Magnet-feldgerät mit kleinen Magnetfeldenergien so genutzt werden. Die in der Tabelle mit einem (E) gekennzeichneten Einträge sind beruhen auf Erfahrungswissen, die mit einem (W) gekennzeichneten beruhen auf wissenschaftliches Wissen aus Studien. Die Studien sind mit einer Nummer gekennzeichnet und werden im Literaturverzeichnis erwähnt.
Bei der Anwendungsempfehlung sind häufig mehrere Geräteeinstellungen angegeben, das bedeutet es werden mehrere Programme hintereinander durchlaufen. Eine Einheit ist mit 15 Minuten angegeben.
Bal bedeutet Wellenschaukel und der gesamte Frequenzbereich wird in 15 Minuten mehrmals durchlaufen. Sie dient als Basisanwendung. Der Zusatz Nut bedeutet Wellenschaukel um die angegebene spezifische Frequenz mit ±4 Hz. Ist nur eine Zahl angegeben, wird die spezifische Frequenz die gesamten 15 Minuten ausgegeben. Zusätzlich wird eine Gerätelokalisation zur Anwendung empfohlen.
| Beschwerde/-n (Wissensquelle) | Geräteeinstellung (in Hz) z.B. Tiny Scan W |
Gerätelokalisation |
| Grundbehandlung (E) | Bal – 7.8 | Solarplexus (oberer Magen) |
| Abszess (E) | 1,2 – 72.5 | Betroffene Region |
| Adnexitis (Eileiter-/Eierstockentz.) (E) | 1.2 – 72.5 | Unterleib |
| Aerophagie (Luftschlucken) (E) | Bal – 220 |
Unterleib |
| Akne (E) | Bal – 1.2 | Kopf u. betroffene Region |
| Alkoholismus (WB1) | Bal – 10 – 100 | Nacken |
| Allergie (E) | Bal – 3.1 – 330 | Solarplexus (oberer Magen) |
| Alzheimer Krankheit (WB2) | 2 – 8 (Nut) | Kopf, Scheitel |
| Amenorrhöe (keine Regelblutung) (E) | 20 – 290 | Kopf u. Unterleib |
| Anergie (mangelnde Fitness) (WP) | 20 – 230 | Brust |
| Angina pectoris (Brustenge) (WB3) | 3 – 230 | Brust |
| Anorexie (Magersucht) (E) | Bal – 10 | Kopf u. Brust |
| Appetitverlust (E) | 10 | Kopf |
| Arteritis (Arterienentzündung) (E) | Bal – 45 – 48 | Betroffene Region |
| Arterienverkalkung (WB4,7) | Bal – 7.8 | Brust |
| Arthritis – akut (WP,B5) | Bal – 1.2 – 50 | Nieren u. betroffene Gelenke |
| Arthritis – chronisch (WP,B5) | Bal – 3 | Nieren |
| Arthrose (WP, B6) | 10 – 28 | Betroffene Region |
| Asthma bronchiale (E) | Bal – 1.2 – 50 | Brust |
| Aufregung (WP) | Bal – 3 – 5 | Kopf |
| Augenentzündung (WB24) | 1.2 – 80 | Stirn – Kopf |
| Ausrenkung (Luxation) (E) | 9 | Betroffene Region |
| Bauchfellwassersucht (E) | 7.8 – 72.5 – 32.5 | Unterleib |
| Bauchspeicheldrüsenschwäche (E) | 10 – 250 | Bauchspeicheldrüse |
| Bettnässen – nächtlich (E) | 3.4 – 72.5 | Blase u. Lendenwirbel |
| Bindehautentzündung (WB24) | 1.2 – 80 | Kopf |
| Blasenentzündung (WB24) | 1.2 – 400 | Unterleib |
| Blasenschwäche (E) | 50 – 72.5 | Unterleib |
| Blutdruck – zu hoch (WB21) | 10 – 100 | Kopf, Scheitel |
| Blutdruck – zu niedrig (WB22) | Bal – 300 | Solarplexus (oberer Magen) |
| Blutgerinnung – erhöht (WB20) | 8 | Brustbein |
| Blutkreislaufschwäche (E) | 50 – 72,5 | Herz u. Leber (abwechseln) |
| Blutkreislaufstörungen (WB9,10) | Bal – 45 – 48 | Waden – Beine – Kopf |
| Bronchitis (E) | 1,2 – 50 | Brust |
| Chirurgische Eingriffe – nach (WB27) | 7.8 | Betroffene Region |
| Crohn, Morbus (E) | Bal – 1.2 – 72.5 | Bauch |
| Darmschleimhautentzündung (E) | 72.5 | Unterleib |
| Darmschleimhautentz. m. Durchf. (E) | 1.2 – 72.5 | Bauch |
| Depression (endogene) (WP, B14) | 1.2 – 72.5 | Solarplexus (oberer Magen) |
| Depression (exogene) (WP, B14) | 700 | Solarplexus (oberer Magen) |
| Diabetes (ergänzende Behandl.) (E) | 34 – 700 | Magen |
| Diabetes-Geschwür (WB50) | 1.2 – 72.5 | Betroffene Region |
| Dickdarmentzündung (E) | 1.2 – 72.5 | Magen |
| Dickdarmentzünd. – Geschwüre (E) | 1.2 – 72.5 | Magen |
| Drüsenentzündung (E) | 1.2 – 72.5 | Betroffene Region |
| Dupuytrensche Kontraktur (E) | 1.2 – 250 | Hände |
| Durchfall – Darmentzündung (E) | 1.2 – 72.5 | Bauch |
| Eierstockentzündung (E) | 1.2 – 72.5 | Unterleib |
| Energiemangel (WP) | 10 – 230 | Brust |
| Entzündungen – allgemein (WB24) | 1.2 – 50 – 72.5 | Betroffene Region |
| Epicondylitis (Tennisarm) (E) | 1.2 – 250 | Schmerzhafte Region |
| Epilepsie (E, WB16) | Siehe Anmerkung | Siehe Anmerkung |
| Epiphyse – Funktionstörung (E) | Bal – 3 – 5 | Kopf |
| Falsch. G.spalt (Pseudarthrose)(WB13) | Bal – 40 – 72.5 | Betroffene Region |
| Fetterhöhung im Blut (E) | 8 | Sternum (Brustbein) |
| Folgen von Infarkten (E) | Bal – 40 | Betroffene Region |
| Furunkulose (E) | 200 – 1175 | Betroffene Region |
| Galle (Schmerzen, Entzündung) (E) | 1.2 – 325 | Bauch |
| Gallenblasenentzündung (E) | 1.2 – 330 | Bauch |
| Gallengefäßentzündung (E) | 1.2 – 325 | Bauch |
| Gefäßschädigungen – Folgen (E) | Bal – 40 | Betroffene Region |
| Gehirngefäßvereng.– Ischämie (E) | Bal | Kopf, Scheitel |
| Geschwächtes Immunsystem (E) |
10 – 230 | Brust |
| Geschwür – allgemein (E) |
1.2 – 72.5 | Betroffene Region |
| Geschwüre beim Wundliegen (WB49) | Bal – 72.5 | Betroffene Region |
| Geschwür – varikös (WB51) | 1.2 – 72.5 | Betroffene Region |
| Gicht (E) | Bal – 3 | Nieren |
| Glaukom (Grüner Star) (WB18) | 50 | Hirn |
| Grüner Star (Glaukom) (WB18) | 50 | Hirn |
| Gürtelrose (Herpes zoster) (E) | 200 – 1000 | Betroffene Region |
| Halsschmerzen (Tonsillitis) (E) | 1.2 – 72.5 | Hals |
| Hämorrhoiden (E) | 1.2 – 72.5 | Analbereich u. Leber |
| Blasenentzündung (E) | 1.2 – 400 | Unterleib |
| Harnleiterentzündung (E) | 1.2 – 400 | Unterleib |
| Haut – allgemeine Beschwerden (E) | 200 – 1000 | Betroffene Region |
| Hepatitis A oder B (WB19) | 1.2 – 2.8 – 28 | Leber |
| Herpes Zoster (Gürtelrose) (E) | 200 – 1000 | Betroffene Region |
| Herzkrampf (Angina pectoris) (WB3) | 3 – 230 | Brust |
| Herzkranzgefäßverengungen (E) | Bal | Herz |
| Herzschwäche (E) | Bal – 8 | Brust |
| Hexenschuss (Lumbago) (WB40) | 9 | Hüfte |
| Immunsystem (schwach) (E) | 10 – 230 | Brust |
| Impotenz (E) | 10 – 90 | Hoden |
| Infektionen (E) | 1.2 – 72.5 | Betroffene Region |
| Ischias (E) | 10 – 130 | Hüfte |
| Kalte Füße (Kreislaufprobleme) (E) | Bal – 40 | Magen |
| Kardiovaskuläre Regeneration (WB9) | 50 – 72,5 | Herz u. Leber (abwechseln) |
| Kiefer/Stirnhöhlenentzündung (E) | 1.2 – 72.5 | Kopf |
| Kniearthrose (WB6) | 5 – 24 | Betroffenes Knie |
| Knochenbruch (WB13) | 7.8 – 220– 72.5 | Betroffene Region |
| Knochenentkalk. (Osteoporose) (E) | 7.8 – 220 – 72.5 | Betroffene Region |
| Konjunktivitis (WB24) | 1.2 – 80 | Kopf |
| Kopfschmerzen (WP, B31) | 2 – 5 – 10 | Kopf, Scheitel |
| Kopfschmerzen – Migräne (WP, B31) | 2 – 5 – 260 | Kopf |
| Krampfadern (E) | 1.2 – 28 | Betroffene Region |
| Krebs – ergänzende Behandl. (WB47) | 32.5 – 50 – 165 | Betroffene Region |
| Laryngitis (WB33) | 1.2 – 72.5 | Hals |
| Leberstoffwechselstörungen (E) | 8.7 – 72.5 | Leber |
| Lebhaftigkeit – vermindert (E) | 27,5 – 60 | Brust |
| Lumbago (Hexenschuss) (WB40) | 9 | Kreuzbein-Lenden-Bereich |
| Lungenfibrose (E) | Bal – 410 – 220 | Brust |
| Lupus (Chronische Hautreizung) (E) | 1.2 – 50 | Sternum (Brustbein) |
| Luxation (Ausrenkung) (E) | 9 | Betroffene Region |
| Lymphstau (E) | 6.3 | Betroffene Region |
| Magenentzündung (E) | 1.2 – 375 | Magen |
| Magengeschwür (E) | 1.2 – 72.5 | Unterleib |
| Magensäure – zu viel (E) | 7.8 – 30 – 230 | Magen |
| Magensäure – zu wenig (E) | 20 | Bauchspeicheldrüse |
| Mandelentzündung (Tonsillitis) (E) | 1.2 – 72.5 | Nacken |
| Menopause-Wechselbeschwerd. (E) | Bal – 72.5 | Unterleib |
| Migräne (einseit. Kopfweh) (WP, B31) | 2 – 5 – 260 | Kopf |
| Mittelohrentzündung (WB33) | 1.2 – 72.5 | Ohr |
| Monatsblutungen (zu stark) (E) | Bal – 3.1 | Unterleib + Kopf (ev. Magen) |
| Monatsblutungen (zu wenig) (E) | Bal – 20 – 290 | Kopf + Unterleib |
| Multiple Sklerose (WB42) | 10 – 50 – 230 | Kopf, Scheitel u. Solarplexus |
| Muskelatrophie – Muskelschwund(E) | 10 – 28 | Betroffene Region |
| Muskelrheumatismus (E) | 1.2 – 50 – 72.5 | Betroffene Region |
| Muskelschwund – Muskelatrophie (E) | 10 – 28 | Betroffene Region |
| Muskelverletzung (WB45) | 10 – 80 | Betroffene Region |
| Myositis (Muskelentzündung) (E) | 1.2 | Betroffene Region |
| Narben – gestört, gereizt (E) | Bal – 18 – 72.5 | Betroffene Region |
| Nasenbluten (E) | 8.7 – 72.5 | Kopf |
| Schnupfen (E) | 1.2 | Kopf |
| Nekrosenbildung (Geschwür) (WB48) | Bal | Betroffene Region |
| Nephrose (E) | 20 – 240 | Nieren |
| Nervenkrankheit – allgemein (WP) | Bal | Nacken |
| Nervenschmerzen – chronisch (E) | Bal – 1.2 – 7.8 | Kopf |
| Nervenstärkung (WP) | Bal – 1 – 5 – 10 | Kopf, Scheitel |
| Nervenstörung (WP) | 0.1 – 0.6 | Kopf, Scheitel |
| Nervenverletzung (WB29) | Bal – 7.8 – 40 | Betroffene Region |
| N.wurzelschmerzen (z.B. Ischias) (E) | 1.2 – 50 | Rücken |
| N.zusammenbruch (endogen) (E) | Bal – 1.2 – 72.5 | Solarplexus (oberer Magen) |
| N.zusammenbruch (exogen) (E) | 700 | Solarplexus (oberer Magen) |
| Nervosität (WP) | 3.1 | Solarplexus (oberer Magen) |
| Neuralgie – chronisch (E) | Bal – 1.2 – 7.8 | Betroffene Region |
| Neuralgie – Trigeminus (E) | Bal – 1000 – 27 | Kopf |
| Neurovegetative Störungen (E) | Bal | Solarplexus (oberer Magen) |
| Neurovegetative Dystonie (E) | Bal – 40 | Kopf |
| Nierenentzündung (WB39) | 1.2 – 72.5 | Nieren |
| Nierenkrankheiten – allgemein (E) | 40 | Nieren |
| Nierenschwäche (E) | 10 – 40 | Rücken, Nieren |
| Obstipation (Verstopfung) (E) | 7.8 – 72.5 | Bauch |
| Ödem (E) | 7.8 – 72.5 | Betroffene Region |
| Ohrgeräusche (WB33) | 10 – 1000 | Kopf |
| Ohrensausen (WB33) | 10 – 1000 | Kopf |
| Ohrentzündung – Mittel (WB33) | 1.2 – 50 – 72.5 | Betroffene Ohr |
| Osteochondrose (E) | 10 – 40 – 72.5 | Hüften |
| Osteochondrose – Wirbelsäule (WB12) | 4.6 – 72.5 | Betroffene Wirbel |
| Osteoporose (WB34) | 50 – 72.5 – 100 | Becken |
| Parese (Lähmung) – spastisch (E) | Bal – 45.5 | Kopf |
| Parese (Lähmung) – träge (E) | Bal – 400 | Betroffene Region |
| Parodontose (WB38) | 30 | Betroffene Gesichtshälfte |
| Parkinsonkrankheit (WB37) | Bal – 2 – 3.1 | Kopf |
| Periadenitis (E) | 1.2 – 72.5 | Betroffene Region |
| Periarthritis (E) | 1.2 – 250 | Betroffene Region |
| Phantomschmerzen (E) | Bal | Betroffene Region |
| Phlebitis (Venenentzündung) (E) | 8 | Betroffene Region |
| Podagra (Gicht) (E) | Bal – 3 | Nieren |
| Polyarthritis – akutes Rheuma (E) | Bal – 3 | Nierenbereich |
| Postoperative Behandlung (WB27) | 78 | Betroffene Region |
| Prellung – Quetschung (E) | 9.1 – 110 | Betroffene Region |
| Prostata – Tumor (E) | Bal – 410 | Prostata |
| Prostatitis (E) | Bal – 225 | Prostata |
| Pseudarthrose (WB13) | Bal – 40 – 72.5 | Betroffene Region |
| Pseudo-Angina-Pectoris (E) | Bal – 220 | Brust |
| Psychosomatische Beschwerden (E) | Bal – 330 | Solarplexus (oberer Magen) |
| Pyelonephritis (N.beckenentz.)(WB39) | Bal – 8 | Niere |
| Quetschung – Prellung (E) | 9.1 – 110 | Betroffene Region |
| Rachenschleimhautentzünd. (WB33) | 1.2 – 72.5 | Hals |
| Rhinorrhagie (Nasenbluten) (E) | 8.7 – 72.5 | Kopf |
| Römheldsyndrom (E) | Bal | Unterleib |
| Rippenfellentzündung (E) | 1.2 – 72.5 | Brust |
| Rückenmarkverletzung (E) | Bal – 7.8 – 40 | Betroffene Region |
| Scheinarthrose (E) | Bal | Betroffene Region |
| Schenkelgeschwür – Unter (WB51) | 1.2 – 72.5 | Bein |
| Schilddrüse – Überfunktion (E) | 3.2 | Nacken |
| Schilddrüse – Unterfunktion (E) | 1.2 – 3.4 – 35 | Nacken |
| Schlaganfall – Folgen (E) | Bal – 40 | Kopf |
| Schlaflosigkeit (WP,B25) | 3 – 5 | Kopf |
| Schlafstörungen (WP,B25) | 3 – 5 | Kopf |
| Schmerzen – allgemein (E) | Bal | Betroffene Region |
| Schnupfen (E) | 1.2 – 72.5 | Kopf |
| Schuppenflechte (E) | 60 – 110 | Betroffene Region |
| Schüttellähmung (Parkinson) (WB37) | Bal – 2 – 3.1 | Kopf |
| Schwäche – ältere Personen (E) | 27.5 – 60 | Brust |
| Schwindel (E) | Bal – 60 | Kopf |
| Sehnen– und Muskelleiden (E) | 1.2 – 250 | Betroffene Region |
| Sehnenscheidenentzündung (WB44) | 1.2 – 250 | Betroffene Region |
| Sklerose –Amyotroph. Lateral- (WB44) | 10 – 28 – 230 | Kopf, Scheitel |
| Spondylarthritis – steife Wirbels. (E) | 10 – 28 – 100 | Rücken, betroffene Region |
| Spondylitis – chronische (E) | Bal – 3 | Betroffene Region |
| Spondylitis – schmerzhafte (E) | 1.2 – 28 – 7.8 | Betroffene Region |
| Tennisarm (Epicondylitis) (E) | 1.2 – 250 | Betroffene Region |
| Thrombophilie (E) | 8 | Sternum (Brustbein) |
| Unruhe – nervöse (WP) | Bal – 3 – 5 | Kopf |
| Variköses Geschwür (WB51) | 1.2 – 72.5 | Betroffene Region |
| Veneninsuffizienz (E) | 1.2 – 28 | Beine |
| Verbrennung (E) | Bal – 200 | Betroffene Region |
| Vernarbung – verstärkte (E) | Bal – 40 – 7,8 | Betroffene Region |
| Verrenkung (E) | 9 | Betroffenen Region |
| Verstopfung (Obstipation) (E) | 7.8 – 72.5 | Bauch |
| Wasseransamml.– Bauchraum (E) | 72.5 | Bauch |
| Wechseljahrbeschwerden (E) | Bal – 72.5 | Unterleib |
| Wirbelsäulenarthrose (WB12) | 5 – 24 | Betroffene Region |
| Wirbelsäule – Osteochondrose (E) | 4.6 – 72.5 | Betroffene Wirbel |
| Wundliegend – Geschwüre (WB49) | Bal – 72.5 | Betroffene Region |
| Zahnchirurgie – nach (WB11) | 72.5 | Betroffene Wange |
| Zahnziehung – nach (WB11) | 7.8 – 72.5 | Betroffene Wange |
| Zirbeldrüse – Funktionstörung (E) | Bal – 3 – 5 | Kopf |
Referenzen Indikationstabelle
1 Alkoholismus (Alcoolisme)
[1] Subrahmanyam S., Satyanarayana M., Rajeswari K.R. „Acoholism: newer methods of management“; Indian Journ. of Physiol. Pharmacol. : 30(1), pp. 43-54 (1986).
2 Alzheimer Demenz (Alzheimer, Maladie d‘-)
[2] Jacobson J.l. „Pineal-hypothalamic tract mediation of picotesla magnetic fields in the treatment of neurological disorders“ Panminerva A1ed. Theoretical physics and advanced studies for biophysical research, Jupiter Fl- 334377 lJSA
[3] Sandyk R. et al. „Age related disruption of circadian rythms: Possible relationship to memory impairment and implication for therapy with magnetic fields“, Internat. Journ. of Neurosci., 59(4), pp. 259-262 (1991).
[4] Sandyk R., „Alzheimer disease: Improvement of visual memory and visuoconstructive performance; treatment with picotesla range magnetic fields“ Internat. Journ. of neuroscience, 76(3-4), pp.185-225 (1994).
3 Angina pectoris (Angine de poitrine)
[5] Orlov L.L., Makoeva L.D., Glezer M.G., Titov Slu, Arzhanenko O.M., Margarian AG., Musev V.A, Memetov K.A, Belinskaia T.F. „Evaluation of anti-running pulse magnetic field and drug therapy on the physical working capacity and hemodynamics in patients with stable angina pectoris“, Kardiologiia, 32(2), pp. 23-26 (1992).
[6] Orlov L.L., Makoeva L.D., Glezer M.G., Memetov, Belinskaia T.F., Arzhanenko O.M., „Effects of impulse magnet field and beta adrenergic blockaders on physical work capacity and hemodynamics of patients with neurocirculatory cardiac type“, Kardiologiia, 31(2), pp. 36-39 (1991)
4 Arterienverengung (Arterite obliterante)
[7] Kucherenko A.E., Shevchuck V.I. „Treatment of various diseases of the limb stumps by altemating magnetic field“; Klin. Khir. Jul., 7, pp. 47-49 (1976).
[8] Kirillov Y.B. et al. „Magnetotherapy in obliterative vascular diseases of lower extremities“, Vopr. Kurortol Fizioter. Lech. Fiz. Kult., 3, pp. 14-17 (1992).
5 Arthritis (Arthrite)
[9] Leclaire P., Bourguin J. „Bioelectromagnetic treatment of shoulder periarthiritis: a randomized controlled trial of the efficiency and tolerance of magnetotherapy“; Arch. Phys. 1\. 1ed. Rehabil., 72: pp. 284-287 (1991).
[10] Riva Sanseverino E., Vannini E., Castellacci P.“Therapeutic effects of pulsed magnetic fields on joint disease“, Panminerva 1\1ed., 34(4), pp. 187-196 (1992).
[11] Shlyapok E.A et al. „Use of alternating low frequency magnetic fields in combination with baths for teatment of juvenile rheumatoid arthritis“ Fizioter. Lech. Fiz. Kult., 4, pp.13-17 (1992).
[12] Grigor’eva V.D. et al. „Therapeutic use of physical factors in complex therapy of patients with psoriatic arthritis“, Vopr. Kurortol Fizioter. Lech Fiz. Kult., 6, pp. 48-51 (1995).
[13] Trock D.H. et al. „The effect of pulsed electromagnetic fields in the treatment of osteoarthritis of the knee and cervical spine. Report of randomized, double blind, placebo controlled trials“, Journ. of Rheumatology, 21(10), pp. 1903-1911 (1994).
6 Arthrose (Arthrose)
[10] Riva Sanseverino E., Vannini A., Castellacci P. „Therapeutic effects of pulsed magnetic fields on joint disease“, Panminerva Med., 34(4), pp. 187-196 (1992).
[14] Trock D.H., Bollet A.J., Dyer R.H. Jr., Fielding L.P., Miner W.K., Markoll R. „A double blind trial of the clinical effects of pulsed electromagnetic fields in osteoarthritis“; Journ. of Rheumatol., 20(3): pp. 456-460 (1993).
[13] Trock D.H. et al. „The effect of pulsed electromagnetic fields in the treatment of osteoarthritis of the knee and cervical spine. Report of randomized, Double blind, Placebo controlled trials“, Journ. of Rheumatol., 21(10), pp. 1903-1911 (1994).
[15] Bollet A.J. „Treatment of osteoarthritis with pulsed electromagnetic fields“, European Bioelectromagnetic Association, 211d. Congress, Bled Slovenia, P.46 , Dec. 1993.
[16] Yurkiv L. „The use of changeable magnetic field in treatment of osteoarthrosis“, European Bioelectromagnetic Association, 3rd. Congress, Nancy (F) Feb-March 1996.
7 Atherosklerose (Atherosclerose)
[17] Gordon R.T., Gordon D. „Selective resolution of plaques and treatment of atherosclerosis by biophysical alteration of „cellular“ and „intracellular properties“; Med. Hypotheses, 7(2), pp. 217-229 (1981).
8 Bronchitis, chronisch (Bronchite chronique)
[18] Iurlov V.M. et al. „The efficacy of the use of low frequency electromagnetic fields in chronic bronchitis“, Voen. 1\1ed. Zh., 3, pp.35-36 (1989).
[19] Mozhaev G.A., Tikhonovskii I. Iu., „The prevention and treatment of suppurative inflammatory complications in the bronchopulmonary system during prolonged artificial ventilation“, Anesthesiol. Reanimatol., 4, pp. 47-51 (2002).
9 Herz-Kreislauf-Regeneration (Cardiovasculaire, Regeneration -)
[20] Dudchenko M.A. et al. „The effect of combined treatment with the use of magnetotherapy on the systemic hemodynamics of patients with ischemic heart disease and spinal osteochondrosis“, Lik. Sprava (5), pp. 40-43 (1992).
[21] Bogdanov N.N., A.khmedzhanov M.Iu., Buiavykh A.G. „Optimization of the effects of physical and health resort factors in ischemic heart disease and hypertension“, Ter. Arkh., 58(5), pp. 108-111(1986).
[22] Gorczynska E. „Fibrinolytical processes in rabbits activated by the magnetic field“; Journ. Hyg. Epidemiol. Microbiol. Immunol., 32(4), pp. 391-396 (1988).
10 Herz-Kreislauf-Erkrankungen (Cardiovasculaires symptomes)
[23] Strelkova N.I., Maslovskaia S.G., Gavrilkov A.G., Strel’tsova E.N. “ Gse of electromagnetic fields in patients after disturbance of cerebral circulation“; Sov. lvfed. 5, pp. 35-38 (1983).
(24] Ezhova L.V., Aklunedzhanov M.Iu., Shatrov AA. „Changes in physical work capacity of patient with myocardial infarction under the effect of graded bicycle training with preliminary action of magnetic field“; Vopr. Kurortol. Fizioter. Lech Fiz. Kult., l, pp. 58-59 (1985).
[6] Orlov L.L., Makoeva L.D., Glezer M.G., Memetov, Belinskaia T.F., Arzhanenko O.M., „Effects of impulse magnet field and beta adrenergic blockaders on physical work capacity and hemodynamics of patients with neurocirculatory cardiac type“, Kardiologiia, 31(2), pp. 36-39 (1991)
[25] Vasil’eva E.M. et al. „The effect of a low frequency magnetic field on erythrocyte membrane function and on the prostanoid level in the blood plasma and on parasystolic arrythmia“ , Vopr. Kurortol. Fizioter. Lech. Fiz. Kult., 2, pp. 18-20 (1994).
[26] Gordon Glen & Preditev: Hot Topics „Pulsed magnetic fields for treatment of cardiovascular sympoms“ Informations Ventures, Feb. 11, 2003.
11 Zahnoperationen, Nachbehandlung (Chirurgie dentaire, Suite de -)
[27] Hillier-Kolarov V. & Pekaric-Nadj N. „Pulsing electromagnetic field therapy as an 51 additional therapy for oral diseases“, European Bioelectromagnetics Association, 1. Congress, Brussels Jan. 1992.
[28] Matsumoto H., Ochi M., Abiko Y., Hirose Y., Kaku T., Sakaguchi K. „Pulsed electromagnetic fields promote bone formation around dental implants inserted into the femur of rabbits“; Clin. Oral Implants Res., 11(4): pp. 354-360 (2000).
12 Arthrose der Wirbelsäule (Colonne vertebrale, Arthrose de la – )
[13] Trock D.H., Bollet A.J., Markoll R.“The effect of pulsed electromagnetic fields in the treatment of osteoarthritis of the knee and cervical spine. Report of randomized, Double blind, Placebo controlled trials“, Journ. of Rheumatology, 2 l(10), pp. 1903-1911 (1994).
13 Knochenheilung (Consolidation osseuse)
[29] Komad K., Sevcic K., Foldes K., Piroska E., Molnar E. „Therapy with pulsed electromagnetic fields in aseptic loosening of total hip protheses: a prospective study“; Clin. Rheumatol., 15(4): pp. 325-328 (1996).
[30] Bassett C.A.L. et al. “ A non operative salvage of surgically-resistant pseudarthroses and non-unions by pulsing electromagnetic fields: A preliminary report“, Clin. Orthoped. and Rel. Research, 124, pp.128-143 (1977).
[31J Bassett C.A.L et al.“Treatment of therapeutically resistant non unions with bone grafts and pulsing electromagnetic fields“ Journal of Bane Joint surg., 64(8) pp. 1214-1220 (1982). (20] Dudchenko M.A. et al. „The effect of combined treatment with the use of magnetotherapy on the systemic hemodynamics of patients with ischemic heart disease and spinal osteochondrosis“, Lik. Sprava (5), pp. 40-43 (1992).
[32] Bassett C.A. „The development and application of pulsed electromagnetic fields for ummited :fractures and arthodeses“, Clin. Plast. Surg., 12(2), pp. 259-277 (1985).
[33] Walustrom 0. „Electromagnetic fi.elds used in the treatment of fresh fractures of the radius“, Bioelectric Repair and Growth Society, Second Annual Meeting, Oxford, Sept. 1982. [34] Marcer M. et al. „Results of pulsed electromagnetic fields in ununited fractures after external skeletal fixation“, Clin. Orthop., 190, pp. 260-265 (1984).
[35] Wahlstrom 0. et al. „Stimulation of fracture healing with electromagnetic fields of extremely low frequency“, Clin. Orthop., 186, pp. 293-301 (1984).
[36] Rajewski F., Marciniak W. et al. „Use of magnetotherapy for treatment of bone malunion in limbs lenghtening. Preliminary report.“ Clin. Ortop. Pol., 57(1-3), pp.247-249 (1992).
[37] Sedel L. et al. „Acceleration of repair of non unions electromagnetic fields“, Rev. Chir. Orthop. Reparatrice App. J.v!ot., 67(1), pp. 11-23 (1981).
[38] Mulier J.C., Spaas. F. et al. „Out patient treatment of surgically resistem non unions induced pulsing current – Clinical Results“, Arch. Orthop. Trauma. Surg., 97(4), pp.293-297 (1980).
[39] Betti E.,Marchetti S., Cadossi R., Faldini A.“Effect of electromagnetic fields stimulation on fractures of the femoral neck. A prospective randomized double blind study“ Electricity and magnetism in Biology and ]v!edicine, Bologna (I), June 1997.
[40] Goldberg A.A. „Computer analysis of data on more than 11 000 cases of ununited fractures submitted for treatment with pulsing electromagnetic fields“, Bioelectrical Repair and Growth Society, Second Annual Meeting, Oxford, Sept. 1982.
[41] Cadossi R. et al. „Low frequency pulsing electromagnetic fields in the treatment of delayed unions and acquired pseudo-arthrosis“, Bioelectrical Repair and Growth Society, Second Annual Meeting, Oxford, Sept. 1982.
[42] Kort J.S. et al. „Congenital pseudarthrosis of the tibia: Treatment with pulsing electromagnetic fields“, Clin. Orthop., 165, pp. 124-137 (1982).
[43J Frykman G.K. et al. „Treatment of non united scaphoid fractures pulsed electromagnetic field and cast“, Journ. of Hand Surgery, 11(3), pp. 344-349 (1986).
[44] Meskens M.W. et al. „Treatment of delayed union and non union of the tibia with pulsed electromagnetic fields. A retrospective follow-up“, Bull. Hosp. lt. Dis. Orthop. Inst., 48(2), pp. 170-175 (1988)
[45] Butenko L.L. „The use of alternating magnetic fields in spinal osteochondrosis: Mechanisms of biological action of electromagnetic fields“, Pushchino USSR, USSR Academy of Science, Research Centerfor Biological Studies, 27 oct. 1987„
[46] Guerkov H.H., Lohmann C.H., Liu Y., Dean D.D., Simon B.J., Heck.man J.D., Schwartz Z., Boyan B.D., „Pulsed electromagnetic fields increase growth factor release by nonunion cells“ ;Clin. Orthop. 384, pp. 265-279 (2001).
[47] Indouraine A., Petersen J_P., Pforringer W. „Effects of low frequency pulsed electromagnetic fields on the proliferation of chondrocytes“; Sportverletz Sportschaden, (DK) 15(1): p. 227 (2001).
[28] Matsumoto H., Ochi M., Abiko Y., Hirose Y., Kaku T., Sakaguchi K. „Pulsed electromagnetic fields promote bone formation around dental implants inserted into the femur of rabbits“; Clin. Oral lmplants Res., 11(4): pp. 354-360 (2000).
[48] Satter Syed A., Islam M.S., Rabbani K.S., Talukder M.S. „Pulsed electromagnetic fields for the treatment of bone fractures“; Bangladesh !Yfed Res. Counc. Bull., 25(1): pp.6-10 (1999).
[49] Roy K.A., Deborah McK. C., Grant J. „Stimulation of experimental endochondral assification by low energy pulsing electromagnetic fields“; Journ. of Bone and Mineral Research, 4(2): pp. 227-233 (1989).
14 Depressionen (Depression nerveuse)
[50] Sandyk R., Anninos P.A., Tsagas N. „Magnetic fields and seasonality of affective illness: implications for therapy“, Internat. J of Neurosci., 58(3-4), pp. 261-267 (1991).
[51] Barker A.T. „An introduction to the basic principles of magnetic nerve stimulation“, JClin. Neurophysiol., 8(1) pp. 26-37 (1991).
[52] Geddes L.A. „History of magnetic stimulation of the nervous system“, J Clin. Neurophysiol. 8(1), pp. 3-9 (1991).
[53] Jacobson L.I., Yamanashi W.S. „A possible physical mechanism in the treatment of neurological disorders with extemally applied picotesla magnetic fields“; Physiol. Chem. Phys. Afed. 26(4): pp. 287-297 (1994).
[54] Maccabee P.J., Arnassian V.E., Cracco R.Q., Cracco J.B., Eberle L., Rudell A. „Stimulation of the human nervous system using the magnetic coil“, J Clin. Neurophysiol. 8(1), pp.38-55 (1991).
15 Schmerzen, allgemein (Douleurs en general)
[55] Markov Marko „Can magnetic and electromagnetic fields be used for pain relief?“ Amercan Pain Society Bulletin, 12(2) Jan-Feb. 2002.
[56] Rauscher E., Van Bise W.L. „Magnetic field control of lower back pain“, FDA-IDE Number G880034 (1998).
[57] Varcaccio-Garofalo G., Carriern C., Loizzo M.R., Arnoruso S., Loizzi P. „Analgesie properties of electromagnetic field therapy in patient with chronic pelvic pain“, Gynecol. 22(4), pp.350-354 (1995).
[58] Ryczko M.C., Persinger M.A. „Increased analgesia to thermal stimuli in rats after brief exposure to complex pulsed 1 microtesla magnetic field“; Percept ivfot. Skills 95(2): pp. 592- 598 (1995).
[59] Navratil L., Hlavaty V., Landsingerova E., „Possible therapeutic applications of pulsed magnetic fields“; Cas. Lek. Cesk., 132(19): pp. 590-594 (1993).
16 Epilepsie (Epilepsie)
[2] Jacobson J.I. „Pineal-hypothalamic tract mediation of picotesla magnetic fields in the treatment of neurological disorders“ Panminerva lvfed. Theoretical physics and advanced studies for biophysical research, Jupiter Fl- 334377 USA.
[60] Sandyk R., Anninos P.A. „Attenuation of epilepsy with application of external magnetic fields: a case report“, Internat. Journ. of Neurosci., 66(1-2), pp. 75-78 (1992).
[61] Anninos P.A., Tsagas N., Sandyk R., Derpapas K. „Magnetic stimulation in the treatment of partial seizures“; Intern. Journ. of Neurosci., 60, pp.141-171 (1991).
17 Kniearthrose (Genou, Arthrose du -)
[13] Trock D.H., Bollet A.J., Markoll R. „The effect of pulsed electromagnetic fields in the treatment of osteoarthritis of the knee and cervical spine. Report of randomized, Double blind, Placebo controlled trials“, Journ. of Rheumatology, 21(10), pp. 1903-1911 (1994).
[62] Jacobson J.I., Gorman R., Yamanashi W.S., Saxena B.B., Clayton L. “ Low amplitude, extremely low frequency magnetic fields for treatment of osteoarthritic knees: A double blind clinical study“; Altern. Ther. Health 1vfed., 7(5): pp.54-64 (2001).
[63] Nicolakis P., Kollmitzer J., Crevenna R., Bittner C., Erdogmus C.B., Nikolakis J. ;Wien Klin. Wochenschr., 114(15-16): pp. 678-684 (2002).
18 Glaukom (Glaucome)
[64] Bisvas et al. „Possibilities of magnetotherapy in stabilization of visual function in patients with glaucoma“ Vestn. Oftalmol., 112(1), pp. 6-8 (1996).
[65] Tsisel’sk.ii Iu.V. et al. „The effect of a pulsed electromagnetic field on ocular hydrodynamics in open angle glaucoma“, Oftalmol. Zh.(Russia), 3: pp. 89-92 (1990).
[66] Tsisel’skii Iu.V., Kashintseva L.T., Skrinnik A.V. „The effect of a pulsed electromagnetic field on the hemodynamics of eyes with glaucoma“, Oflalmol Zh. (Russia): 3, pp. 154-157 (1990).
[67] Skripka V.K. „Results of the use of magnetic field in ophtalmology“, Oftalmol. Zh. (Russia), 36(6), pp. 321-325 (1981).
[68] Vainshtein E.S., Zobina LV., Gurtovaia E.E. „Altemating magnetic field in the treatment of various eye diseases of vascular etiology“, Oftalmol. Zh., 36(6), pp. 325-328, (198 1).
19 Hepatitis A und B (Hepatite A et B)
[69] Krasnov V.V. & Shilenok AI. „Magnetotherapy of hepatitis A and B in children“, Pediatriia, 10 pp. 54-57, (1991). 20 Blutgerinnung, erhöht (Hypercoagulabilite sanguine)
[70] Temur’iants N.A., Mikhailov A.V. „Effect of weak alternating ultra-low frequency magnetic fields on the development of the hypercoagulation syndrome in immobilized rats“, Biofizika, 30(6): pp. 1046-1049 (1985).
21 Hypertonie (Hypertension)
[71] Orlov L.L., Alekseeva N.P., Galuza G.I., Slutskii I.I., Drosdov Iu. F. „Hemodynamic and humoral mechanisms of the therapeutic effect of the „travelling“ impulse magnetic field in hypertension“, Vopr. Kurortol. Fizioter. Lech. Kult., 1, pp. 23-27(1985)
[72] Orlov L.L., Alekseeva N.P., Slutskii I.I., Galuza G.I., Chogovadze V.A. „Various homoral factors regulating blood pressure in patiems with hypertension during treatment by an impulse magnetic field“, Kardiologiia, 26(3), pp. 56-60 (1986).
[73] Pruzinski A. et al. „Pulsating electromagnetic field in the therapy of headache“, Journ. of Bioelectricity, 7(1), pp. 127-128 (1988).
[74] Orlov L.L. et al. „Indications for using a new magnetotherapeutic method in arterial hypertension“, Soviel A1edicine, 8, pp. 23-24 (1991).
[6] Orlov L.L, Makoeva L.D., Glezer M.G., Memetov K.A., Belinskaia T.F., Arzhanenko 0.\11. „Effects of impulse magnet field and beta adrenergic blockaders on physical work capacity and hemodynamics of patients with neurocirculatory dystonia of the cardiac type“ ; Kardiologiia, 31(2) pp. 36-39 (1991).
[75] Miasnikov I.G. „Magnetotherapy of initial manifestations of cerebrovascular disorders in hypertension“, Zh. Nevropatol. Psikhiatr. Im SS Korsakova, 92(1), pp. 63-67(1992).
[76] Ivanov S.G. et al. „Use of magnetic fields in the treatment of hypertensive disease“, Vopr. Kurortol. Fizioter. Lech Kult., 3, pp. 67-69 (1993).
[77] Zadionchenko V.S. et al. „Prognostic criteria of the efficacy of magnetic and magnetic laser therapy in patients suffering from the initial stage of hypertension“, Vopr. Kurortol. Fizioter. Lech. Kult. , 1, pp. 8-11 (1997).
[78] Drobyshev V.A., Filippova G.N., Loseva M.I., Shpagina L.A., Shelepova N .V., Zhelezniak M.S., „The use of low frequency magnetotherapy and EHF puncture in the combined treatment of arterial hypertension in vibration-induced disease“; Vopr. Kurorto l. Fizioter. Lech. Fiz. Kult. , May-June 2000, pp. 9-11 (2000).
22 Hypotonie (Hypotension)
[79] Orlov L.L. et al. „Effect of a running pulse magnetic field on some humoral indices and physical capacity in patients with neurocirculatory hypotension“, Biofizika, 41(4), pp. 944-948 (1996).
23 Inkontinenz (Incontinence urinaire)
[80] Jerabek J. „Pulsed magnetotherapy m Czechosovakia – a review“; Rev. Envion. Health,10( 2): pp. 127-134 (1994).
24 Entzündungen (lnflammations)
[59] Navratil L.,Hlavaty V., Land singerova E., „Possible therapeutic applications of pulsed magnetic fields“; Cas. Lek. Cesk., 132(19): pp. 590-594 (1993).
[80] Jerabek J. „Pulsed magnetotherapy in Czechosovak.ia – a review“; Rev. Envion. Health, 10(2): pp. 127-134 (1994).
25 Schlaflosigkeit, Schlafstörungen (Insomnies)
[81] Ennan M. „Low-energy emission therapy treatment for insomnia“, Bioelectromagnetics Society, 131 . Annual Meeting, Abstracts p. 69, Salt Lake City, June 1991.
[82] Hadjuk.ovic R. „Efects of low energy emission therapy on sleep structure“, First World Congress for Electricity and ivfagnetism in Biology and 1vfedicine, Abstracts p. 92, Lake Buena Vista, June 1992.
[83] Guilleminault C., Pasche B. „Clinical effects of low energy emission therapy“, Bioelectromagnetics Society, 15th Annual Meeting, Abstracts p. 84, Los Angeles, June 1993. [84] Pelka R.B., Jaenicke C., Gruenwald J. „Pulsed mgnetic field therapy for insomnia: A double-blind, placebo controlled study“; Adv. Ther. 18(4), pp. 174-180 (2001).
26 Venöse Insuffizienz (Insuffisance veineuse)
[85] Pasynkov E.I., Konstantinova G.D., Vlasova E.I. „Therapeutic use of alternating magnetic field in the treatment of patients with chronic diseases of the veins of the lower limbs“ ; Vopr. Kurortol. Fiziother. Lech. Fiz. Kult., 5 pp. 16-19 (1976).
[86] Galimzianov F.V. et al. „Electromagnetic therapy after phlebectomy“; Khirurgiia (Moskow), 5, pp. 108-110 (1990).
[87] Dovganiuk A.P. „Balneologie and physical therapy of chronic venous insufficiency of extremities“; Vopr. Kurortol Fizioter. Lech Fiz. Kult., 2, pp. 48-49 (1995).
[80] Jerabek J. „Pulsed magnetotherapy in Czechosoval<.ia – a review“ ; Rev. Envion. Health,10(2): pp. 127-134 (1994).
27 Operationen, Folgebehandlung (Intervention chirurgicale, suites d‘-)
[88] Perjes K. et al. „Effect of magnetotherapy on recovery after herniated disk surgery“, 2nd. Hungarian Symposium on 1vfagnetotherapy, Szekesfehervar, pp. 159-162-76, May 1987.
28 Ischämie, zerebrale (Ischemie cerebrale)
[89] Strelkova N.I., Maslovskaia S.G., Gavrilkov A.G., Strel’tsova E.N. “ Use of electromagnetic fields in patients after disturbance of cerebral circulation“; Sov. l’vfed. 5, pp. 35-38 (1983).
[90] Grant G., Cadossi R., Steinberg G. „Protection against focal cerebral ischemia following exposure to a pulsed electromagnetic field“; Bioelectromagnetics, 15(3) pp. 205-216 (1994).
29 Nervenverletzungen (Lesions nerveuses)
[91] Zobina L.V. „Effectiveness of magnetotherapy in optic nerve atrophy: A preliminary study“, Vestn. Oftalm ol., 106(5), pp. 54-47 (1990).
[92] Walker J.L., Evans J.M., Resig Ph., Guamieri S., Meade Ph., Sisken B.S. „Enhancem ent of functional recovery following a crush lesion to the rat sciatic nerve by axposure to pulsed electromagnetic fields“; Exper imental Neurology, 125: pp.302 -305 (1994).
30 Lupus erythematodes (Lupus erythemateux)
[93] Khamaganova I.V., Berlin Iu.V., Volkov V.E., Volnich Z.V., Arutiunova E.S. 1’The use of a pulsed magnetic field inthe treatment of lupus erythemaosus“; Ter. Arkh., 67( 10) pp. 84- 87 (1995).
31 Kopfschmerzen (Maux de tete)
[94] Grunner 0. et al. “Cerebral use of a pulsating magnetic field in neuropsychiatry patients with long term headache“, EEG E.A1G Z Elektroenzephalogr. Verwandte Geb., 16(4), pp.227- 230 (1985).
[95] Giczi J. & Guzeo A. „Treatment of headache with pulsating electromagnetic field: a preliminary report“, 2nd_ Hungarian Symposium an Magnetotherapy, Szekesfehervar, pp. 74- 76, May 1987.
[96] Lazar L. & Farago A. „Experiences of patients suffering from migraine-type headache, treated with magnetotherapy“, 2nd_ Hungarian Symposium an lvfagnetotherapy, Szekesfehervar, pp. 137-140, May 1987.
[73] Pruzinski A. et al. „Pulsating electromagnetic field in the therapy of headache“, Journ. of Bioelectricity, 7(1), pp. 127-128 (1988)
32 Migräne, chronisch (Migraines chroniques)
[95] Giczi J. & Guzeo A. „Treatment of headache with pulsating electromagnetic field: a preliminary report“, rd. Hungarian Symposium an lvfagnetotherapy, Szekesfehervar, pp. 74-76, May 1987.
[96] Lazar L. & Farago A. „Experiences of patients suffering from migraine-type headache, treated with magnetotherapy“, 2nd_ Hungarian Symposium on lvfagnetotherapy, Szekesfehervar, pp. 137-140, May 1987.
[73] Pruzinski A. et aL „Pulsating electromagnetic field in the therapy of headache“, Journ. of Bioelectricity, 7(1), pp. 127-128 (1988)
[97] Mix E., Jenssen H.L., Lehmitz R., Lakner K., Hitzschke B., Richter M., Heydemeich A. „Effect of pulsating electromagnetic field therapy on cell volume and phagocytosis activity in multiple sclerosis and migraine“, Psychiatr. l’1eurol. lvfed Psychol. (Leipz.), 42(8), pp.457- 466 (1990).
33 Hals-Nase-Ohren (HNO), Entzündungen (O.R.L., Inflammations -)
[80] Jerabek J. „Pulsed magnetotherapy m Czechosovakia – a review“; Rev. Envion. Health,10( 2): pp. 127-134 (1994).
[98] Ozinkovskii V.V. „Use of a low frequency pulsing electromagnetic field in treating inflammatory diseases of the E.N.T. organs“; Zh. Ushn. Nos. Gor!. Bolezn., 3, pp.51-53 (1980).
[99] Bogomil’skii M.R., Sapozhnikov Lam, Salavskii A.I., Tarutin N.P. „The treatment of hypoacusis in children by using a pulsed low frequency electromagnetic field“; Vestn. Otorinolaringol., pp. 23-26, 1996.
[100] Tarasov D.I., Nicolaev M.P., Aliev M.A. „Effectiveness of local magnetic field of the acoustic frequency in the treatment of patients with acute inflammatory diseases of the larynx“; Vestn. Otorinolaringol., pp. 11-15, 1995.
[101] Roland N.J., Hugues J.B., Daley M.B., Cook J.A., Jones A.S., McCormick M.S. „Electromagnetic stimulation as a treatment of tinnitus: a pilot study“; Clin. Otorinolaryngol. 18, pp. 278-281 (1993).
[102] Sunstov V.V. „Treatment of acute diffuse otitis externa low frequency magnetic fields“ , Vestn. Otorinolaringol.; 6, pp.35-38 (1991).
34 Osteoporose (Osteoporose)
[103] Bilotta T.W. „The use of low frequency, low magnitude, pulsing electromagnetic field in treatment of osteoporosis“, Journ. of Bioelectricity, 8(2), p. 316 (1989).
[l04] Saveriano G., Ricci S. „Treatment of senile osteoporosis caused rachialgia with low frequency pulsed electromagnetic fields“, Journ. of Bioelectricity, 8(2), p. 321(1989).
[105] Tabrah F. et al. „Bone density changes in osteoporosis in women exposed to pulsed electromagnetic fields“, Journ. of Bane J\1iner. Res., 5(5), pp. 437-442 (1990).
[106] Bilotta T.W. Inf1uence of pulsed electromagnetic fields on post-menopausal osteoporosis“, First World Congressfor Electricity and A1agnetism in Biology and j \1edicine, p. 78, Lake Buena Vista, June 1992
[107] Zati A., Gnudi S., Mongiorgi R., Giardino R., Fini M., Valore G., Galliani I, Montagnani A.M. „Effects of pulsed magnetic fields in the therapy of osteoporosis induced by ovarectomy in the rat“; Ball. Soc. ltal. Bio!. Sper., 69, pp.469-475 (1993).
35 Pankreatitis, chronisch (Pancreatite chronique)
[l08] Fedorov A.A. „The use of low frequency magnetic field in the combined therapy of chronic pancreatitis“, Vopr. Kurortol. Fizioter. Lech. Fiz. Kult., 5, pp. 28-30 (1990).
36 Periphere Lähmungen (Paralysie peripherique et paresis)
[109] Mecseki L. „The study of the efficacy of magnetotherapy in peripheral paralysis“, 2nd. Hungarian Symposium on 1\1agnetotherapy, Szekesfehervar, pp. 149-158, May 1987.
37 Parkinsonkrankheit (Parkinson, Maladie de -)
[2] Jacobson J.I. „Pineal-hypothalamic tract mediation of picotesla magnetic fields in the treatment of neurological disorders“ Panminerva J\lled Theoretical physics and advanced studies for biophysical research, Jupiter Fl- 334377 USA.
[110] Sandyk R. & Iacono R.P. „Reversal of visual neglect in Parkinson disease treatment with picotesla range magnetic fields“ Internat. Journ. of Neurosci., 73(1-2), pp. 93-107 (1993).
[111] Sandyk R. „Weak magnetic fields in the treatment of Park.inson disease with the „on off ‚ phenomenon“, Intern. Journ. of Neurosci., 66, pp. 97-106 (1992).
[112] George M.S. et al. „Transcranial magnetic stimulation: A neuropsychiatric tool for the 21st century“, Journ. of Neuropsychiatry Clin. Neurosci., 8(4) pp. 373-382 (1996).
[80] Jerabek J. „Pulsed magnetotherapy in Czechosovak:ia – a review“; Rev. Envion. Health,10(2): pp. 127-134 (1994).
38 Paradontose (Parodontoses)
(113] Chelidze L.N., Zhengti T.G., Devdariani E.S., Khomeriki R.V. „Use of an electromagnetic field for treating parodontosis“, Stomatologiia (Moscow), 59(2), pp.91-92 (1980).
[114] Todorov N., Ignatova B., Stojanova 0. „Application of low frequency impulse magnetic fields and other medications in the treatment of patients with hemorrhagic periodontosis“, Stomatologiia (Sofia), 65(6): pp. 20-24 (1983).
39 Nierenbeckenentzündung/Pyelonephritis (Pyelonephrite)
[115] Kiyatkin V.A. „Pulsed magnetic field in therapy of patients with secondary chronic pyelonephritis“ (Revue de plusieurs articles), Second World Congress for Electricity and magnetism in biology and medicine, June 1997, Bologna (I).
40 Lumbalgie (Radiculopathie lombaire)
[116] Sheriff M.K. „Neuromodulation of detrusor hyper-reflexia functional magnetic stimulation of the sacral roots“, British Journ. of Urology, 78(1) pp. 39-46 (1996).
41 Rheumatismus (Rhumatismes)
[80] Jerabek J. „Pulsed magnetotherapy in Czechosovakia – a review“; Rev. Envion. Health,10( 2): pp. 127-134 (1994).
42 Multiple Sklerose (Sclerose en plaques)
[117] Guseo A. „Electromagnetic field therapy of multiple sclerosis: the Gyuling-Bordacs Device; Double blind, cross-over and open stu.dies“; Journ. of Bioelectr., 6(1): pp.23-27, (1987).
[117bJ Guseo A. „Double-blind treatrnents with pulsating electromagnetic field in multiple sclerosis“; 2nd Hungarian Symposium on Magnetotherapy, pp. 85-89, 16-17 May 1987.
[97] Mix E., Jenssen H.L., Lehm.itz R., Lakner K., Hitzschke B., Richter M., Heydenreich A. „Effect of pulsating electromagnetic field therapy on cell volume and phagocytosis activity in multiple sclerosis and migraine“, Psychiatr. Neurol. A1ed. Psychol. (Leipz.), 42(8), pp.457- 466 (1990).
[2] Jacobson J.I. „Pineal-hypothalamic tract mediation of picotesla magnetic fields in the treatment of neurological disorders“ Panrninerva A1ed Theoretical physics and advanced studies for biophysical research, Jupiter Fl- 334377 USA.
[80] Jerabek J. „Pulsed magnetotherapy in Czechosovakia – a review“; Rev. Envion. Health,10( 2): pp. 127-134 (1994).
[118] Sandyk R. „Rapid normalization of visual evoked potentials picotesla range magnetic fields in chronic progressive multiple sclerosis“, Internat. J. of Neurosci., 77(3-4), pp. 243- 259 (1994).
[119] Sandyk R. „Reversal of alexia in multiple sclerosis by weak electromagnetic fields“, Internat. J. of l‘-leurosci., 83( 1-2), pp.69-79 (1995).
[120] Sandyk R. „Resolution of dysarthria in multiple sclerosis treatrnent with weak electromagnetic fields“, Internat. Journ. of Neurosci., 83(1-2), pp. 81-92, (1995).
[121J Sandyk R. „Treatment with electromagnetic fields alters the clirrical course of chronic progressive multiple sclerosis: a case report“, Internat. Journ. of Neurosci., 88(1-2), pp. 75-82 (1996).
[122] Sandyk R. „Progressive cognitive improvement in multiple sclerosis from treatrnent with electromagnetic fields“, Internat. Journ. of Neurosci., 89(1-2), pp.29-38 (1997).
[123] Sandyk R. „Treatment with electromagnetic fields reverses the long term clinical course of a patient with chronic progressive multiple sclerosis“ ; Intern. Journ. of Neurosci. 90(3-4), pp. 177-185 (1997).
[124] Sandyk R. „Serotonergic neuronal atrophy with synaptic inactivation, not axonal degeneration, are the main hallmarks of multiple sclerosis“ ; Intern. Journ. of Neurosci.: 95(1-2), pp. 133-140 (1998).
[125] Bardasano J.L., Ramirez E., De la Hoz J., Ramos J.L., Picazo M.L.; „Extracranial device for non invasive neurological treatment with pulsating extremely low frequency magnetic fields“, 2nd World Congressfor Electricity and A1agnetism in Biology and A1edicine, Bologna (I), June 1997.
[126] Richards T.L., Lappin M.S., Acosta-Urquidi J., Kraft G.H., Heide AC., Lawrie F.W., Merrill T.E., Melton G.B., Cunningham C.A. „Double blind stu.dy of pulsing magnetic field effects on multiple sclerosis“; Journ. Altern. Complement. Afed. 3(1), p.229 (1997) and 3(2), p.205 (1997).
43 Amylotrophe Lateralsklerose (Sclerose laterale amyotrophique)
[127] Bellosi A., Berget R. „Pulsed magnetic fields: A glimmer of hope for patient suffering from amyotrophic lateral sclerosis“, Second World Congressfor Electricity and lvfagnetism in Biology and A1edicine, Bologna, (1), june 1997.
44 Sehnenscheidenentzündung (Tendinites)
[128] Binder A., Parr G., Hazleman B., Fitton-Jackson S. “ Pulsed electromagnetic field therapy of persistent rotator cuff tendinitis: A double-blind controlled assessment“, The Lancet, 1(8379): pp. 695-698 (1984).
[129] Chard M.D., Hazleman B.L. „Pulsed electromagnetic field treatment of chronic lateral humeral epicondylitis“, Clin. Exp. Rheumatol., 6(3), pp. 330-332 (1988).
45 Muskuläre Verletzungen (Traumatismes musculaires)
[130] Nikolova L., Popov A., Klouchek E. „Effect of classical drugs and low frequency magnetic field on tissue regeneration“; Vopr. Kurortol. Fizioter. Lech. Fiz. Kult., 3, pp. 19-23 (1984).
[131] Sisken B.F., Walker J. „Therapeutic aspects of electromagnetic fields for soft-tissue healing“ in Electromagnetic fields: Biological Interactions and A1echanisms, Ed. Blank pp.277-285 (1995).
46 Stimmungsschwankungen (Troubles de l’humeur)
[50] Sandyk R., Anninos P.A., Tsagas N. „Magnetic fields and seasonality of affective illness: implications for therapy“, Internat. J of Neurosci., 58(3-4), pp. 261-267 (1991).
47 Krebstumore (Tumeurs cancereuses)
[132] Ogorodnikova L.S. et al. „Morphological criteria of lung cancer regression under the effect of magnetotherapy“, Vopr. Onkol., 26(1), p. 2834, (1980).
[133] Bakhmutskii N.G. et al. „The assessment of the efficacy of the effect of a rotational magnetic field on the course of the tumor process in patients with cancer“, Sov. Med., 7, pp.25-27 (1991).
[134] Bakhmutskii N.G. et al. „The growth dynamics of Walker Carcinosarcoma during exposure to a magnetic eddy field“, Vopr. Onkol., 37(6), pp. 705-708 (1991).
[135] Randoll U. & Pangan R.M. „Role of complex biophysical/chemical therapies for cancer“ Bioelectrochemistr and Bioenergetics., 27(3) pp.341-346 (1992).
[136] Ornate Y. „An experimental attempt to potentiate therapeutic effects of combined use of pulsing magnetic fields and antitumor agents“, Nippon G., 8 pp. 1155-1166 (Aug. 1988). [137] Ogorodnikova L.S. et al. „Morphological criteria of lung cancer regression under the effect of magnetotherapy“, Vopr. Onkol., 26(1), pp. 28-34 (1980).
[138] Smimova V. „Anti-tumorigenic action of an eddy magnetic field“, Vrach, 2, pp. 25-26 (1994).
[139] Zhang X., Zhang H., Zheng C., Li C., Xiong W. „Extremely low frequency pulsed gradient magnetic field inhibit malignant tumour growth at different biological levels“; Cell Bio!. lnt., 26(7): pp. 599-603 (2002).
48 Geschwüre, nekrotisierend (Ulcere necrotique)
[140] Pasynkov E.I. et al. „Therapeutic use of altemating magnetic field in the treatrnent of patients with chronic diseases of the veins of the lower limbs“ ; Vopr. Kurortol. Fiziother. Lech. Fiz. Kult., 5 pp. 16-19 (1976)
[141] Alekseenko A.V. Gusak V.V. „Treatment of trophic ulcers of the lower extremities using a magnetic field“, Klin. Khir., 7 pp. 60-63 (1991).
49 Geschwüre, Dekubitus- (Ulcere de decubitus)
[142] Comorosan S., „The effect of pulsed magnetic therapy on the healing of decubitus ulcer“, Romanian Journ. of Physiol., 30(1-2), pp. 41-45 (1993).
50 Geschwüre, diabetisch (Ulceres du diabetique)
[143] Kirillov I.B., Succhkova Z.V., Lastushkin A.V., Sigaev A.A., Nekhaeva T.I. „Magnetotherapy in the comprehensive treatment of vascular complications of diabetes mellitus“, Klin. A1ed., 74(5), pp. 36-41 (1996).
[144] Kuliev R.A. & Babaev R.F. „A magnetic field in the combined treatment of suppurative wounds in diabetes mellitus 11 Vestn. Khir lm l.l. Grek, 148(1), p.3336 (1992).
[145] Kuliev R.A., Babaev R.F., Akhmedova L.M., Ragimova A.I. „Treatment of suppurative wounds in patients with diabetes mellitus magnetic field and laser irradiation 1 Khirurgliia (7,8), pp. 30-33 (1992).
51 Geschwüre, varicös, venös (Ulceres variqueux)
[146] Pasynkov E.I. et al. „Therapeutic use of alternating magnetic field in the treatment of patients with chronic diseases of the veins of the lower limbs“ ; Vopr. Kurortol. Fiziother. Lech. Fiz. Kult., 5 pp. 16-19 (1976)
[147] Ieran M., Zaffuto S., Bagnacani M.,Annovi M., Moratti A., Cadossi R. „Effect of low frequency pulsing electromagnetic fields on skin ulcers of venous origin in humans; A double-blind study“; J Orthop. Res. );far., 8(2) pp. 276-282 (1990).
[148] Sieron et al. „Use of magnetic field in treatment of trophic leg ulcers“; Pol. Tyg. Lek., 46 (36-39), pp. 717-719 (1991).
[149] Stiller ).1.J., Pak G.H., Shupack J.L., Thaler S., Kenny C., Jondreau L. „A portable pulsed electromagnetic field device to enhance healing of recalcitrant venous ulcers: A double-blind, placebo controlled clinical trial“, Brit. Journ. of Dermatol., 127(2), pp. 147-154 (1992).
[150] Duran V., Zamurovic A.,Stojanovic S, Poljacki M., Jovanovic M., Durisic S. „Therapy of venous ulcers using pulsating electromagnetic fields- personal results“, Klinika za infektivne i dermatoveneroloske bolesti, Afedicinski Facultet Sad., Med Pregl 44(11-12), pp. 485-488(1991).
[151] Todd D.J., Heylings D.J., Allen G.E., McMillin W.P. (Dermatology, Belfast city Hospital) „Treatment of cluonic varicose ulcers with pulsed electromagnetic fields: A controlled pilot study“, Ir. Afed; Journ. , 84(2), pp. 54-55 (1991). Mechanismen der Magnettherapie mit pulsierenden Feldern und allgemeine Prinzipien (Mecanismes de la magnetotherapie par champs pulses et principes generaux)
[152] Bassett C.A.L. „Beneficial effects of electromagnetic fields“, Journ. of Cellular Biochemistry; 51, pp. 387-393 (1993).
[153] Luben R.A. „Membrane signal transduction as a site of electromagnetic field actions in bone and other tissues“ ex: On the nature of electromagnetic field interaction with biological systems, Chapter 7, pp.83-98, Ed. Allan H. Ferry, Medical Intelligence Unit, (1994)
[154] Bassett C.A.L. „Fundamental and practical aspects of therapeutic uses of pulsed electromagnetic fields“, Crit. Rev. Biomed. Engineering 17, pp.451-529 (1989).